THE HALL PRACTICE
CALCOT MED CTR, HAMPDEN RD, CHALFONT ST. PETER, GERRARDS CROSS
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 16 | 19 | 84.2% | |
| HF 4 | 2011 | 20 | 31 | 64.5% | |
| HF 4 | 2012 | 18 | 22 | 81.8% | |
| HF 4 | 2013 | 24 | 28 | 85.7% | |
| HF004 | 2014 | 12 | 14 | 85.7% | |
| HF004 | 2015 | 13 | 15 | 86.7% | |
| HF004 | 2016 | 11 | 13 | 84.6% | |
| HF004 | 2017 | 14 | 15 | 93.3% | |
| HF004 | 2019 | 17 | 19 | 89.5% | |
| HF004 | 2020 | 34 | 38 | 89.5% | |
| HF006 | 2021 | 39 | 46 | 84.8% | |
| HF006 | 2022 | 37 | 44 | 84.1% | |
| HF006 | 2023 | 43 | 44 | 97.7% |
